MedTrace Logo

Patient Outcomes Using an Expandable Spacer

NCT03162666 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-08-23

No results posted yet for this study

Summary

This study is a post-market clinical follow-up study. The data collected from this study will serve the purpose of confirming safety and performance of the ALTERA™ Expandable implant.

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

ALTERA

degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. with up to grade 1 spondylolisthesis

Sponsors & Collaborators

  • Globus Medical Inc

    lead INDUSTRY

Principal Investigators

  • Kern Singh, MD · Rush Univeristy Medical Center Orthopedic Surgeon

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2020-11-06
Completion
2020-11-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03162666 on ClinicalTrials.gov